Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.
|Stifel Nicolaus Healthcare Conference|
|Thursday, September 6, 2012|
|9:45 a.m. Eastern Time|
|Four Seasons, Boston, MA|
|NewsMakers in the Biotech Industry Conference|
|Friday, September 7, 2012|
|8:30 a.m. Eastern Time|
|Millennium Broadway Hotel, New York, NY|
|Morgan Stanley Global Healthcare Conference|
|Monday, September 10. 2012|
|10:35 a.m. Eastern Time|
Grand Hyatt, New York, NY
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly-owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib partnered with AstraZeneca, MEK162 partnered with Novartis, and danoprevir, partnered with InterMune / Roche, having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013. For more information on Array, please go to www.arraybiopharma.com.